Cargando…

FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder

BACKGROUND: Idiopathic REM sleep behavior disorder is a prodromal stage of Parkinson's disease and dementia with Lewy bodies. Hyposmia, reduced dopamine transporter binding, and expression of the brain metabolic PD‐related pattern were each associated with increased risk of conversion to PD. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Meles, Sanne K., Vadasz, David, Renken, Remco J., Sittig‐Wiegand, Elisabeth, Mayer, Geert, Depboylu, Candan, Reetz, Kathrin, Overeem, Sebastiaan, Pijpers, Angelique, Reesink, Fransje E., van Laar, Teus, Heinen, Lisette, Teune, Laura K., Höffken, Helmut, Luster, Marcus, Kesper, Karl, Adriaanse, Sofie M., Booij, Jan, Leenders, Klaus L., Oertel, Wolfgang H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655750/
https://www.ncbi.nlm.nih.gov/pubmed/28734065
http://dx.doi.org/10.1002/mds.27094
_version_ 1783273595674296320
author Meles, Sanne K.
Vadasz, David
Renken, Remco J.
Sittig‐Wiegand, Elisabeth
Mayer, Geert
Depboylu, Candan
Reetz, Kathrin
Overeem, Sebastiaan
Pijpers, Angelique
Reesink, Fransje E.
van Laar, Teus
Heinen, Lisette
Teune, Laura K.
Höffken, Helmut
Luster, Marcus
Kesper, Karl
Adriaanse, Sofie M.
Booij, Jan
Leenders, Klaus L.
Oertel, Wolfgang H.
author_facet Meles, Sanne K.
Vadasz, David
Renken, Remco J.
Sittig‐Wiegand, Elisabeth
Mayer, Geert
Depboylu, Candan
Reetz, Kathrin
Overeem, Sebastiaan
Pijpers, Angelique
Reesink, Fransje E.
van Laar, Teus
Heinen, Lisette
Teune, Laura K.
Höffken, Helmut
Luster, Marcus
Kesper, Karl
Adriaanse, Sofie M.
Booij, Jan
Leenders, Klaus L.
Oertel, Wolfgang H.
author_sort Meles, Sanne K.
collection PubMed
description BACKGROUND: Idiopathic REM sleep behavior disorder is a prodromal stage of Parkinson's disease and dementia with Lewy bodies. Hyposmia, reduced dopamine transporter binding, and expression of the brain metabolic PD‐related pattern were each associated with increased risk of conversion to PD. The objective of this study was to study the relationship between the PD‐related pattern, dopamine transporter binding, and olfaction in idiopathic REM sleep behavior disorder. METHODS: In this cross‐sectional study, 21 idiopathic REM sleep behavior disorder subjects underwent (18)F‐fluorodeoxyglucose PET, dopamine transporter imaging, and olfactory testing. For reference, we included (18)F‐fluorodeoxyglucose PET data of 19 controls, 20 PD patients, and 22 patients with dementia with Lewy bodies. PD‐related pattern expression z‐scores were computed from all PET scans. RESULTS: PD‐related pattern expression was higher in idiopathic REM sleep behavior disorder subjects compared with controls (P = 0.048), but lower compared with PD (P = 0.001) and dementia with Lewy bodies (P < 0.0001). PD‐related pattern expression was higher in idiopathic REM sleep behavior disorder subjects with hyposmia and in subjects with an abnormal dopamine transporter scan (P < 0.05, uncorrected). CONCLUSION: PD‐related pattern expression, dopamine transporter binding, and olfaction may provide complementary information for predicting phenoconversion. © 2017 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.
format Online
Article
Text
id pubmed-5655750
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-56557502017-11-01 FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder Meles, Sanne K. Vadasz, David Renken, Remco J. Sittig‐Wiegand, Elisabeth Mayer, Geert Depboylu, Candan Reetz, Kathrin Overeem, Sebastiaan Pijpers, Angelique Reesink, Fransje E. van Laar, Teus Heinen, Lisette Teune, Laura K. Höffken, Helmut Luster, Marcus Kesper, Karl Adriaanse, Sofie M. Booij, Jan Leenders, Klaus L. Oertel, Wolfgang H. Mov Disord Brief Reports BACKGROUND: Idiopathic REM sleep behavior disorder is a prodromal stage of Parkinson's disease and dementia with Lewy bodies. Hyposmia, reduced dopamine transporter binding, and expression of the brain metabolic PD‐related pattern were each associated with increased risk of conversion to PD. The objective of this study was to study the relationship between the PD‐related pattern, dopamine transporter binding, and olfaction in idiopathic REM sleep behavior disorder. METHODS: In this cross‐sectional study, 21 idiopathic REM sleep behavior disorder subjects underwent (18)F‐fluorodeoxyglucose PET, dopamine transporter imaging, and olfactory testing. For reference, we included (18)F‐fluorodeoxyglucose PET data of 19 controls, 20 PD patients, and 22 patients with dementia with Lewy bodies. PD‐related pattern expression z‐scores were computed from all PET scans. RESULTS: PD‐related pattern expression was higher in idiopathic REM sleep behavior disorder subjects compared with controls (P = 0.048), but lower compared with PD (P = 0.001) and dementia with Lewy bodies (P < 0.0001). PD‐related pattern expression was higher in idiopathic REM sleep behavior disorder subjects with hyposmia and in subjects with an abnormal dopamine transporter scan (P < 0.05, uncorrected). CONCLUSION: PD‐related pattern expression, dopamine transporter binding, and olfaction may provide complementary information for predicting phenoconversion. © 2017 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society. John Wiley and Sons Inc. 2017-07-22 2017-10 /pmc/articles/PMC5655750/ /pubmed/28734065 http://dx.doi.org/10.1002/mds.27094 Text en © 2017 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Reports
Meles, Sanne K.
Vadasz, David
Renken, Remco J.
Sittig‐Wiegand, Elisabeth
Mayer, Geert
Depboylu, Candan
Reetz, Kathrin
Overeem, Sebastiaan
Pijpers, Angelique
Reesink, Fransje E.
van Laar, Teus
Heinen, Lisette
Teune, Laura K.
Höffken, Helmut
Luster, Marcus
Kesper, Karl
Adriaanse, Sofie M.
Booij, Jan
Leenders, Klaus L.
Oertel, Wolfgang H.
FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder
title FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder
title_full FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder
title_fullStr FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder
title_full_unstemmed FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder
title_short FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder
title_sort fdg pet, dopamine transporter spect, and olfaction: combining biomarkers in rem sleep behavior disorder
topic Brief Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655750/
https://www.ncbi.nlm.nih.gov/pubmed/28734065
http://dx.doi.org/10.1002/mds.27094
work_keys_str_mv AT melessannek fdgpetdopaminetransporterspectandolfactioncombiningbiomarkersinremsleepbehaviordisorder
AT vadaszdavid fdgpetdopaminetransporterspectandolfactioncombiningbiomarkersinremsleepbehaviordisorder
AT renkenremcoj fdgpetdopaminetransporterspectandolfactioncombiningbiomarkersinremsleepbehaviordisorder
AT sittigwiegandelisabeth fdgpetdopaminetransporterspectandolfactioncombiningbiomarkersinremsleepbehaviordisorder
AT mayergeert fdgpetdopaminetransporterspectandolfactioncombiningbiomarkersinremsleepbehaviordisorder
AT depboylucandan fdgpetdopaminetransporterspectandolfactioncombiningbiomarkersinremsleepbehaviordisorder
AT reetzkathrin fdgpetdopaminetransporterspectandolfactioncombiningbiomarkersinremsleepbehaviordisorder
AT overeemsebastiaan fdgpetdopaminetransporterspectandolfactioncombiningbiomarkersinremsleepbehaviordisorder
AT pijpersangelique fdgpetdopaminetransporterspectandolfactioncombiningbiomarkersinremsleepbehaviordisorder
AT reesinkfransjee fdgpetdopaminetransporterspectandolfactioncombiningbiomarkersinremsleepbehaviordisorder
AT vanlaarteus fdgpetdopaminetransporterspectandolfactioncombiningbiomarkersinremsleepbehaviordisorder
AT heinenlisette fdgpetdopaminetransporterspectandolfactioncombiningbiomarkersinremsleepbehaviordisorder
AT teunelaurak fdgpetdopaminetransporterspectandolfactioncombiningbiomarkersinremsleepbehaviordisorder
AT hoffkenhelmut fdgpetdopaminetransporterspectandolfactioncombiningbiomarkersinremsleepbehaviordisorder
AT lustermarcus fdgpetdopaminetransporterspectandolfactioncombiningbiomarkersinremsleepbehaviordisorder
AT kesperkarl fdgpetdopaminetransporterspectandolfactioncombiningbiomarkersinremsleepbehaviordisorder
AT adriaansesofiem fdgpetdopaminetransporterspectandolfactioncombiningbiomarkersinremsleepbehaviordisorder
AT booijjan fdgpetdopaminetransporterspectandolfactioncombiningbiomarkersinremsleepbehaviordisorder
AT leendersklausl fdgpetdopaminetransporterspectandolfactioncombiningbiomarkersinremsleepbehaviordisorder
AT oertelwolfgangh fdgpetdopaminetransporterspectandolfactioncombiningbiomarkersinremsleepbehaviordisorder